CI Atlas · Was It Worth It? Measuring Quality of Life and the Cost of an Implant · Module 05

5Does It Help? Quality-of-Life Gains in Adults

Cochlear implantation in deaf adults reliably lifts measured health-related quality of life. This module quantifies that gain, names the instruments that capture it, identifies who benefits most, and traces the evidence from single-sided deafness through the elderly to the cognition-loneliness-depression axis.

THow Big Is the Gain?

Profound adult deafness carries a mean health-utility decrement of about -0.46 on a 0.00 (death) to 1.00 (perfect health) scale, ranging across studies from -0.36 to -0.63. Pooled across seven studies (n=520), implantation raises adult utility by about +0.26 (95% CI +0.24 to +0.28); single-study gains span +0.07 to +0.42. Generic instruments (HUI Mark III, EQ-5D, SF-6D) register mostly non-hearing domains and underestimate hearing-specific benefit. Disease-specific NCIQ (60 items, 6 domains) and CIQOL-35/CIQOL-10 capture sound perception, listening effort, and social handicap.[2009][1996][2001][2019]

TWhich Instrument Sees What

CIQOL (PROMIS/COSMIN; validated in 705 users, 70.5% response, 17 languages) spans communication, emotional, entertainment, environment, listening effort, and social. HHIE (elderly) and HHIA (under 65), 25 items each, split into emotional and social/situational subscales; HHIE improves about 8.7 points by 18 months. SSQ (49 items) and SSQ12 score 0-10 across speech, spatial, and quality; CI users cluster below 5.0 and near zero on spatial items. Disease-specific tools detect gains generic questionnaires render ambiguous, so a CI battery pairs a generic utility measure with a CI-specific profile.[2019][1982][2004][2024]

The unilateral adult implant ($12,847/QALY) sits inside the NICE band and is unambiguously good value. Single-sided deafness ($20-40k) and the elderly recipient ($25-50k) straddle the $50,000 line because their QALY gain is smaller or sustained over fewer years. The second implanted ear ($50-150k+) routinely breaches every threshold — the added benefit over one implant is real but modest, which is why bilateral funding is the hardest sell. Numbers near $12,847 are illustrative; the harder-case ranges are illustrative. Illustrative.

CWho Benefits Most

Shorter deafness duration and younger age predict better speech and larger utility gains; deafness over 30 years shows markedly reduced benefit. Postlingual adults outperform prelingual adults because preserved auditory cortical function is protective. The Niparko/Wilson-Cleary model runs biology to symptom to function to HRQoL, modulated by personality, motivation, and supports. Music perception lags speech, though training yields modest gains over 12 weeks.[2009][1995][2009]

CSSD, the Elderly, and the Cognition Link

Single-sided deafness implantation shows favorable cost-utility of roughly $20,000-$40,000 per QALY from restored spatial cues and hearing in noise. In adults 65 and older, CI stays cost-effective at about $25,000-$50,000 per QALY, and age does not substantially raise cost per benefit. Predictive models support elderly implantation, and family-level stress, depression, and anxiety reductions persist out to 54 months. QoL gain operates through social participation and emotional well-being, the pathway linking untreated hearing loss to loneliness, depression, and cognitive decline.[2005][1998][1995]

Case 20.5 · Does It Help? Quality-of-Life Gain

A 71-year-old retired schoolteacher with a 6-year history of progressive bilateral sensorineural hearing loss, now profoundly deaf, has withdrawn from her book club and family dinners and screens positive for depression. She spoke normally until her hearing failed in her sixties. Her aided open-set sentence score is 12%. She worries she is too old for an implant.

Which counseling statement is best supported by the quality-of-life and cost-utility evidence?

Self-assessment — Module 52 questions

Question 1

Pooled across seven adult cochlear-implant studies, what is the approximate mean health-utility gain after implantation on a 0.00 (death) to 1.00 (perfect health) scale?

Question 2

Why do generic preference-based instruments (HUI Mark III, EQ-5D, SF-6D) tend to UNDERESTIMATE cochlear-implant benefit compared with disease-specific tools like the NCIQ or CIQOL?

Tracked locally in your browser — see /progress for the dashboard.